A feasibility study of the Nativis Voyager(®) device in patients with recurrent glioblastoma in Australia

AIM: Evaluation of the Nativis Voyager(®), an investigational medical device, as monotherapy for recurrent glioblastoma (rGBM). MATERIALS & METHODS: A total of 15 patients with rGBM were treated with one of two Voyager ultra-low radio frequency energy cognates: A1A or A2HU. Safety and clinical u...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Michael, Dowling, Anthony, Thien, Christopher, Priest, Emma, Morgan Murray, Donna, Kesari, Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Clinical Trial Evaluation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499017/
https://www.ncbi.nlm.nih.gov/pubmed/30727742
http://dx.doi.org/10.2217/cns-2018-0017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499017/
https://www.ncbi.nlm.nih.gov/pubmed/30727742
http://dx.doi.org/10.2217/cns-2018-0017

Ejemplares similares